Last update 04 Apr 2025

GSK-3858279

Overview

Basic Info

Drug Type
Antibody
Synonyms
GSK 3858279, GSK3858279
Target
Action
antagonists
Mechanism
CCL17 antagonists(C-C motif chemokine ligand 17 antagonists)
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetic peripheral neuropathic painPhase 2
United States
20 Sep 2023
Diabetic peripheral neuropathic painPhase 2
China
20 Sep 2023
Diabetic peripheral neuropathic painPhase 2
Japan
20 Sep 2023
Diabetic peripheral neuropathic painPhase 2
Canada
20 Sep 2023
Diabetic peripheral neuropathic painPhase 2
France
20 Sep 2023
Diabetic peripheral neuropathic painPhase 2
Germany
20 Sep 2023
Diabetic peripheral neuropathic painPhase 2
Poland
20 Sep 2023
Diabetic peripheral neuropathic painPhase 2
South Africa
20 Sep 2023
Diabetic peripheral neuropathic painPhase 2
South Korea
20 Sep 2023
Diabetic peripheral neuropathic painPhase 2
Spain
20 Sep 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
97
(Part A: Cohort 1: GSK3858279)
yhwmkvewee = kkbaxsdwyk mjrfsoigti (pyrcvjxvol, tkzrfrxfgc - yqqjskeqlu)
-
22 Mar 2024
(Part A: Cohort 2: GSK3858279)
yhwmkvewee = pzdsyyiczo mjrfsoigti (pyrcvjxvol, xxyeumgdlr - gsezgwadep)
Phase 1
21
Placebo
(Placebo)
qqneojriuq(yswfcskzmg) = kxvkqxwwsf grizptqwxl (lezziknkkh, dndphaotzo - rkfnwukvlh)
-
01 Aug 2023
(GSK3858279 3 mg/kg IV)
qqneojriuq(yswfcskzmg) = hamrqvjviv grizptqwxl (lezziknkkh, uibmsjzhyw - vdroynqqen)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free